安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Purdue Pharma
Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers
- Purdue Pharma L. P. Files New Plan of Reorganization Providing for More . . .
Stamford, Conn – March 18, 2025 – Purdue Pharma L P (“Purdue”) today filed a Chapter 11 Plan of Reorganization (the “Plan”) and related disclosure statement with the United States Bankruptcy Court for the Southern District of New York Assuming full creditor participation, the Plan will deliver to creditors more than $7 4 billion
- Products - Purdue Pharma
Today, Purdue offers a unique portfolio of public health initiative products and medical products in 5 categories: Public Health Initiative Products; Prescription Opioids; See the list of Authorized Distributors of Purdue products Please review Purdue Pharma Returns Goods Policy for Prescription Products
- Medicines From Purdue - Purdue Pharma
Purdue is a pioneer in healthcare, with a patient-first approach in developing medicines We combine medical science with compassionate care in every phase of drug research and manufacturing For each prescription medication listed below, you can readily access the MEDICATION GUIDE and FULL PRESCRIBING INFORMATION when you click on the links
- Restructure - Purdue Pharma
In March 2025, Purdue Pharma L P filed a new Chapter 11 Plan of Reorganization and related disclosure statement with the United States Bankruptcy Court for the Southern District of New York Read the press release here
- FDA Accepts Filing of New Drug Application for . . . - Purdue Pharma
STAMFORD, Conn , April 08, 2024 – Purdue Pharma L P (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection* If the auto-injector is approved, it would be the second nalmefene-containing medicine developed by Purdue to
- News Media - Purdue Pharma
STAMFORD, Conn , August 7, 2024 – Purdue Pharma L P (“Purdue”) announced today that the U S Food and Drug Administration (FDA) approved the Company’s new drug application for the Zurnai™ (nalmefene injection) Auto-Injector Zurnai (zur nye) is a single-dose…
- Study Examining Use of Nalmefene HCI Injection for Opioid Overdose . . .
STAMFORD, Conn , Sept 30, 2024 – Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency department (ED) settings Researchers are now conducting data analysis, with study results expected later this year
|
|
|